Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study

NCT ID: NCT03122808

Last Updated: 2023-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

264 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-01

Study Completion Date

2021-10-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Excessive uterine activity may be one of several aetiological factors that contribute to depressed neurological function in the newborn. During labour, uterine contractions can compress the fetal cranium at pressures high enough to impair cerebral perfusion. Contraction rates greater than 7 in 15 minutes are associated with an increased risk of neonatal encephalopathy.

The American Congress of Obstetricians and Gynecologists defines uterine tachysystole as more than 5 contractions in 10 minutes, averaged over a 30-minute window. By this definition, excessive uterine activity is common and, at best, a non-specific predictor of depressed neurological function in the newborn. There is a need for predictors of neonatal encephalopathy that are more specific and clinically applicable.

Contraction and relaxation duration are two measures that closely reflect the proposed role of excessive uterine activity in the pathogenesis of neonatal encephalopathy. Prolonged contractions with short relaxation periods result in progressive reductions in fetal cerebral oxygenation. Shorter uterine contraction periods are associated with an increased risk of low umbilical cord potential of hydrogen (pH) values.

Our primary aim is to measure parameters of uterine activity, for example relaxation and contraction duration, and determine their relationship with the risk of neonatal encephalopathy. We will also investigate how measures of uterine activity interact with other measures of labour and fetal well-being, including cervical dilation rates and fetal heart rate patterns. In babies with neonatal encephalopathy, we will investigate the relationship of uterine activity with electrophysiological, radiological and developmental outcomes.

We will perform a retrospective case-control study of babies born in the Rotunda hospital from 2005 until the present. The assessor of the Cardiotocograph (CTG) recordings will be blind to the disease status of the infants. For each recording, every uterine contraction and rest interval will be measured. Summary variables created from these measures will be used to compare the case and control groups. The primary variable will be mean rest interval duration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The advent of therapeutic hypothermia has improved outcomes for babies born with hypoxic-ischemic encephalopathy. However, the risk of death, seizures, cerebral palsy or intellectual impairment remains significant, especially among the most severely affected infants. Prevention remains a promising strategy to reduce the incidence of complications arising from hypoxic-ischaemic neonatal encephalopathy.

Excessive uterine activity may be one of several aetiological factors that contribute to depressed neurological function in the newborn. During labour, uterine contractions can compress the fetal cranium at pressures high enough to impair cerebral perfusion. Contraction rates greater than 7 in 15 minutes are associated with an increased risk of neonatal encephalopathy.

The American Congress of Obstetricians and Gynecologists defines uterine tachysystole as more than 5 contractions in 10 minutes, averaged over a 30-minute window. By this definition, excessive uterine activity is common and, at best, a non-specific predictor of depressed neurological function in the newborn. There is a need for predictors of neonatal encephalopathy that are more specific and clinically applicable.

Contraction and relaxation duration are two measures that closely reflect the proposed role of excessive uterine activity in the pathogenesis of neonatal encephalopathy. Prolonged contractions with short relaxation periods result in progressive reductions in fetal cerebral oxygenation. Shorter uterine contraction periods are associated with an increased risk of low umbilical cord pH values.

Our primary aim is to measure parameters of uterine activity, for example relaxation and contraction duration, and determine their relationship with the risk of neonatal encephalopathy. We will also investigate how measures of uterine activity interact with other measures of labour and fetal well-being, including cervical dilation rates and fetal heart rate patterns. In babies with neonatal encephalopathy, we will investigate the relationship of uterine activity with electrophysiological, radiological and developmental outcomes.

We will perform a retrospective case-control study of babies born in the Rotunda hospital from 2005 until the present. Cases and controls must be over 35 weeks gestational age and have at least 15 minutes of Cardiotocograph (CTG) recording from labour available for analysis. Cases will be babies with moderate or severe neonatal encephalopathy of apparent hypoxic-ischemic aetiology. Controls will be the first healthy babies born before and after the cases to satisfy the study criteria. Controls will be matched for parity.

The assessor of the CTG recordings will be blind to the disease status of the infants. For each recording, every uterine contraction and rest interval will be measured. Summary variables created from these measures will be used to compare the case and control groups. The primary variable will be mean rest interval duration.

For further detail please see the study protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Encephalopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neonatal encephalopathy

The inclusion criteria will be:

* Moderate or severe neonatal encephalopathy
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn

The exclusion criteria will be:

* Non-hypoxic-ischaemic aetiology or postnatal hypoxic-ischaemia
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available

Uterine Activity Analysis

Intervention Type DIAGNOSTIC_TEST

Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.

Partogram Analysis

Intervention Type DIAGNOSTIC_TEST

Analysis of slope of partogram

Control

The inclusion criteria will be:

* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn

The exclusion criteria will be:

* APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes
* Admission to the neonatal unit
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available

Uterine Activity Analysis

Intervention Type DIAGNOSTIC_TEST

Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.

Partogram Analysis

Intervention Type DIAGNOSTIC_TEST

Analysis of slope of partogram

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Uterine Activity Analysis

Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.

Intervention Type DIAGNOSTIC_TEST

Partogram Analysis

Analysis of slope of partogram

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Moderate or severe neonatal encephalopathy
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn


* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn

Exclusion Criteria

* Non-hypoxic-ischaemic aetiology or postnatal hypoxic-ischaemia
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available Controls


* APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes
* Admission to the neonatal unit
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Rotunda Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Breda Hayes

Consultant Neonatologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Breda Hayes, MD

Role: PRINCIPAL_INVESTIGATOR

The Rotunda Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Rotunda Hospital

Dublin, Co. Dublin, Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-2015-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.